Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BMY vs GSK✓SelectedUSD · GSKBMY vs GSK performance historyLatest closeAs of+0.79%11/20
Stock and ETF performance explorer

BMY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+26.8%
GSK return
+40.7%
Excess return
-13.9%
Maximum drawdown
-47.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.8%-0.1%+0.9%+0.8%
7D-7.3%-5.3%-2.0%-5.2%
30D-3.8%-3.7%-0.1%-2.3%
3M-9.3%-7.3%-2.0%-6.5%
6M+2.6%-4.2%+6.9%+4.5%
YTD+13.9%+0.9%+13.0%+13.7%
1Y+33.7%+7.3%+26.4%+30.6%
3Y+38.5%+52.7%-14.2%+19.3%
All+26.8%+40.7%-13.9%+9.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling